Dose-response relation, neuromuscular blocking action, intubation conditions, and cardiovascular effects of Org 9273, a new neuromuscular blocking agent
- PMID: 1674648
Dose-response relation, neuromuscular blocking action, intubation conditions, and cardiovascular effects of Org 9273, a new neuromuscular blocking agent
Abstract
The ED50 and the ED90, the time-course of the neuromuscular block, the intubation conditions, and the cardiovascular effects of Org 9273, a new steroidal nondepolarizing neuromuscular blocking agent, have been evaluated in 41 anesthetized patients. From cumulative dose-response curves the ED50 and ED90 were calculated to be 175 and 300 micrograms/kg, respectively. The time-course of neuromuscular blockade after 300- and 500-micrograms/kg doses of Org 9273 appeared to be similar to that of equipotent doses of vecuronium. The neuromuscular block was characterized by a fast initial rate of block development. High-dose Org 9273 (1 mg/kg = 3-4 times the ED90) had a clinical duration comparable to an intubating dose of pancuronium, but a considerably more rapid onset and recovery index. Three hundred micrograms per kilogram and 500 micrograms/kg Org 9273 produced good to excellent intubation conditions 1 min after administration. Org 9273 in a dose of 0.5-2 times the ED90 produced no cardiovascular changes; however, 3-4 times the ED90 increased heart rate 20%-25% (P less than 0.001), probably due to a vagolytic effect.
Similar articles
-
Structure:action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anesthetized cat.Anesthesiology. 1988 Jul;69(1):57-62. Anesthesiology. 1988. PMID: 2898902
-
[The dose-response relationship and time course of the neuromuscular blockade by alcuronium].Anaesthesist. 1990 Oct;39(10):508-12. Anaesthesist. 1990. PMID: 1980578 German.
-
Cardiovascular and neuromuscular effects of Org NC 45, pancuronium, metocurine, and d-tubocurarine in dogs.Anesth Analg. 1980 Jan;59(1):26-30. Anesth Analg. 1980. PMID: 7188662
-
New neuromuscular blocking drugs.N Engl J Med. 1995 Jun 22;332(25):1691-9. doi: 10.1056/NEJM199506223322507. N Engl J Med. 1995. PMID: 7760871 Review.
-
Recent advances in neuromuscular blocking agents.Am J Health Syst Pharm. 1999 Jun 1;56(11 Suppl 1):S14-7. doi: 10.1093/ajhp/56.S14. Am J Health Syst Pharm. 1999. PMID: 10437712 Review.
Cited by
-
Neuromuscular pharmacology update.J Anesth. 1992 Jul;6(3):332-40. doi: 10.1007/s0054020060332. J Anesth. 1992. PMID: 15278545 No abstract available.
-
Neuromuscular transmission and its pharmacological blockade. Part 2: Pharmacology of neuromuscular blocking agents.Pharm World Sci. 1997 Feb;19(1):13-34. doi: 10.1023/a:1008641427473. Pharm World Sci. 1997. PMID: 9089750 Review.
-
Preliminary investigations of the clinical pharmacology of three short-acting non-depolarizing neuromuscular blocking agents, Org 9453, Org 9489 and Org 9487.Can J Anaesth. 1994 Mar;41(3):213-20. doi: 10.1007/BF03009833. Can J Anaesth. 1994. PMID: 7910526
-
Clinical pharmacology of ORG 7617, a short-acting non-depolarizing neuromuscular blocking agent.Eur J Clin Pharmacol. 1994;46(3):225-9. doi: 10.1007/BF00192553. Eur J Clin Pharmacol. 1994. PMID: 7915236
MeSH terms
Substances
LinkOut - more resources
Full Text Sources